Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice

Acta Neuropathologica

Volumn 126, Issue 4, 2013, Pages 555-573

  Rey, Nolwen L ^a   Petit, Geraldine H ^a   Bousset, Luc ^b   Melki, Ronald ^b   Brundin, Patrik ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b CNRS   (France)

^c VAN ANDEL INSTITUTE   (United States)

Author keywords

Microglia; Olfactory bulb; Olfactory pathway; Parkinson's disease; Transfer; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; MOLECULAR WEIGHT; MOUSE; NERVE CELL; NONHUMAN; OLFACTORY BULB; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN TRANSPORT; TRANSPORT KINETICS; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; AXONAL TRANSPORT; BRAIN; CELL COUNT; COLORING AGENTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MICE; MICE, INBRED C57BL; MICROGLIA; NEURAL PATHWAYS; OLFACTORY BULB; PARKINSON DISEASE; RECOMBINANT PROTEINS; STEREOTAXIC TECHNIQUES;

EID: 84885470591     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1160-3     Document Type: Article

References (64)

1. Angot E, Brundin P (2009) Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease. Park Relat Disord 15(Suppl 3):S143-S147
2. Angot E, Steiner JA, Lema Tome CM, Ekstrom P, Mattsson B, Bjorklund A, Brundin P (2012) Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS One 7(6):e39465
3. Ariesandi W, Chang CF, Chen TE, Chen YR (2013) Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization. PLoS One 8(1):e53487
4. Bae EJ, Lee HJ, Rockenstein E, Ho DH, Park EB, Yang NY, Desplats P, Masliah E, Lee SJ (2012) Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission. J Neurosci 32(39):13454-13469
5. Braak H, Del Tredici K (2004) Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 25(1):19-23
6. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197-211
7. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318(1):121-134
8. Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110(5):517-536
9. Bridgman PC (2004) Myosin-dependent transport in neurons. J Neurobiol 58(2):164-174
10. Brown A (2003) Axonal transport of membranous and nonmembranous cargoes: a unified perspective. J Cell Biol 160(6):817-821
11. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev 9(10):741-745
12. Canavan SV, Mayes LC, Treloar HB (2011) Changes in maternal gene expression in olfactory circuits in the immediate postpartum period. Front Psychiatry 2:40
13. Chai YJ, Kim D, Park J, Zhao H, Lee SJ, Chang S (2013) The secreted oligomeric form of alpha-synuclein affects multiple steps of membrane trafficking. FEBS Lett
14. Cinelli AR, Ferreyra-Moyano H, Barragan E (1987) Reciprocal functional connections of the olfactory bulbs and other olfactory related areas with the prefrontal cortex. Brain Res Bull 19(6):651-661
15. Cleland TA, Linster C (2003) Central olfactory structures. In: Doty RL (ed) Handbook of olfaction and gustation. Marcel Dekker, New York, pp 165-181
16. Conway KA, Harper JD, Lansbury PT Jr (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39(10):2552-2563
17. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97(2):571-576
18. Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B (2009) Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 111(1):192-203
19. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106(31):13010-13015
20. Doty RL (2012) Olfaction in Parkinson's disease and related disorders. Neurobiol Dis 46(3):527-552
21. Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8(6):329-339
22. Dunning CJ, Reyes JF, Steiner JA, Brundin P (2012) Can Parkinson's disease pathology be propagated from one neuron to another? Prog Neurobiol 97(2):205-219
23. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838-6851
24. Fauvet B, Mbefo MK, Fares MB, Desobry C, Michael S, Ardah MT, Tsika E, Coune P, Prudent M, Lion N, Eliezer D, Moore DJ, Schneider B, Aebischer P, El-Agnaf OM, Masliah E, Lashuel HA (2012) Alpha-synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem 287(19):15345-15364
25. Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72(4):517-524
26. Ghee M, Melki R, Michot N, Mallet J (2005) PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly. FEBS J 272(16):4023-4033
27. Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev 2(7):492-501
28. Gottfried JA, Wilson DA (2011) Smell In: Gottfried JA (ed) Neurobiology of sensation and reward. CRC Press, Boca Raton, FL
29. Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P (2011) Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121(2):715-725
30. Hardy J (2005) Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration. Biochem Soc Trans 33(Pt 4):578-581
31. Hawkes CH, Del Tredici K, Braak H (2007) Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599-614
32. Hawkes CH, Del Tredici K, Braak H (2010) A timeline for Parkinson's disease. Park Relat Disord 16(2):79-84
33. Hintiryan H, Gou L, Zingg B, Yamashita S, Lyden HM, Song MY, Grewal AK, Zhang X, Toga AW, Dong HW (2012) Comprehensive connectivity of the mouse main olfactory bulb: analysis and online digital atlas. Front Neuroanat 6:30
34. Illig KR, Eudy JD (2009) Contralateral projections of the rat anterior olfactory nucleus. J Comp Neurol 512(1):115-123
35. Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70(4):462-468
36. Jensen PH, Li JY, Dahlstrom A, Dotti CG (1999) Axonal transport of synucleins is mediated by all rate components. Eur J Neurosci 11(10):3369-3376
37. Jonsson O, Steffen AC, Sundquist VS, Janson J, Martinsson S, Maatta U, Emanuelsson AB (2013) Capillary microsampling and analysis of 4-μl blood, plasma and serum samples to determine human alpha-synuclein elimination rate in mice. Bioanalysis 5(4):449-462
38. Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE (2012) Alpha-synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol
39. Kazantsev AG, Kolchinsky AM (2008) Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease. Arch Neurol 65(12):1577-1581
40. Kita H, Kitai ST (1990) Amygdaloid projections to the frontal cortex and the striatum in the rat. J Comp Neurol 298(1):40-49
41. Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ (2008) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 40(9):1835-1849
42. Lee HJ, Suk JE, Bae EJ, Lee SJ (2008) Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372(3):423-428
43. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949-953
44. Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med
45. Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 106(47):20051-20056
46. Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136(Pt 4):1128-1138
47. Mohedano-Moriano A, de la Rosa-Prieto C, Saiz-Sanchez D, Ubeda-Banon I, Pro-Sistiaga P, de Moya-Pinilla M, Martinez-Marcos A (2012) Centrifugal telencephalic afferent connections to the main and accessory olfactory bulbs. Front Neuroanat 6:19
48. Mook Jo S, Kuk Kim Y, Wang Z, Danscher G (2002) Retrograde tracing of zinc-enriched (ZEN) neuronal somata projecting to the olfactory bulb. Brain Res 956(2):230-235
49. Nagayama S, Enerva A, Fletcher ML, Masurkar AV, Igarashi KM, Mori K, Chen WR (2010) Differential axonal projection of mitral and tufted cells in the mouse main olfactory system. Front Neural Circuits 4
50. Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M (2010) Seeded aggregation and toxicity of α-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 285(45):34885-34898
51. Oztas E (2003) Neuronal tracing. Neuroanatomy 2:2-5
52. Price JL (1987) The central olfactory and accessory olfactory structures. In: Finger TE, Silver WL (eds) The neurobiology of taste and smell. Wiley, New York, pp 179-203
53. Raisman G (1972) An experimental study of the projection of the amygdala to the accessory olfactory bulb and its relationship to the concept of a dual olfactory system. Exp Brain Res 14(4):395-408
54. Reyher CK, Schwerdtfeger WK, Baumgarten HG (1988) Interbulbar axonal collateralization and morphology of anterior olfactory nucleus neurons in the rat. Brain Res Bull 20(5):549-566
55. Roy S, Zhang B, Lee VM, Trojanowski JQ (2005) Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol 109(1):5-13
56. Scott DA, Das U, Tang Y, Roy S (2011) Mechanistic logic underlying the axonal transport of cytosolic proteins. Neuron 70(3):441-454
57. Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA (2000) Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci USA 97(9):4897-4902
58. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839-840
59. Tang Y, Das U, Scott DA, Roy S (2012) The slow axonal transport of alpha-synuclein-mechanistic commonalities amongst diverse cytosolic cargoes. Cytoskeleton (Hoboken) 69(7):506-513
60. Ulusoy A, Rusconi R, Perez-Revuelta BI, Musgrove RE, Helwig M, Winzen-Reichert B, Monte DA (2013) Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol Med 5(7):1119-1127
61. Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72(1):57-71
62. Waxman EA, Giasson BI (2010) A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. J Neurochem 113(2):374-388
63. Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C, Loher T, Vilar M, Campioni S, Tzitzilonis C, Soragni A, Jessberger S, Mira H, Consiglio A, Pham E, Masliah E, Gage FH, Riek R (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108(10):4194-4199
64. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhou Y, Hong JS, Zhang J (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. Faseb J 19(6):533-542